Showing results (741-750 of 785) with videos related to
Sort By:
Pageof 79
The American Journal of Clinical Nutrition|September 25, 2015
High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trialNestan Tukvadze, Ekaterina Sanikidze, Maia Kipiani, et al.European Journal of Medicinal Chemistry|February 10, 2015
Pyridine C-region analogs of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonistsHyungChul Ryu, Sejin Seo, Jee-Young Lee, et al.Biorxiv : the Preprint Server for Biology|March 18, 2024
Rare Variable M. tuberculosis Antigens induce predominant Th17 responses in human infectionPaul Ogongo, Liya Wassie, Anthony Tran, et al.Bioorganic & Medicinal Chemistry|February 26, 2004
Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 bindingJeewoo Lee, Su Yeon Kim, Soyoung Park, et al.ACS Chemical Biology|February 2, 2013
Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1Noemi Kedei, Nancy E Lewin, Tamás Géczy, et al.Bioorganic & Medicinal Chemistry|September 17, 2013
TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamidesTae-Hwan Ha, Hyungchul Ryu, Sung-Eun Kim, et al.Plos One|October 12, 2018
High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humansJeffrey M Collins, Douglas I Walker, Dean P Jones, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2012
A phospholipase C-γ1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant miceRobert L Kortum, Alexandre K Rouquette-Jazdanian, Michihiko Miyaji, et al.International Journal of Radiation Oncology, Biology, Physics|November 6, 2018
Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified ChemoradiotherapyKevin A Pearlstein, Kyle Wang, Robert J Amdur, et al.Bioorganic & Medicinal Chemistry Letters|May 5, 2015
α-Substituted 2-(3-fluoro-4-methylsulfonamidophenyl)acetamides as potent TRPV1 antagonistsPhuong-Thao Tran, Ho Shin Kim, Jihyae Ann, et al.Pageof 79